作者更正：重症监护室潜在药物相互作用的评估。

IF 3.3 4区医学 Q1 Medicine European review for medical and pharmacological sciences Pub Date : 2024-10-01 DOI:10.26355/eurrev_202410_36861

M S Dagdelen, D Gulen, I Ceylan, N K Girgin

{"title":"作者更正：重症监护室潜在药物相互作用的评估。","authors":"M S Dagdelen, D Gulen, I Ceylan, N K Girgin","doi":"10.26355/eurrev_202410_36861","DOIUrl":null,"url":null,"abstract":"Correction to: Eur Rev Med Pharmacol Sci 2021; 25 (18): 5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 published online on September 30, 2021. The methodology section of this research article incorrectly stated that the lexi-interact checker program is freely accessible. The study was conducted at Uludağ University using university-access computers. As a result, the lexi-interact program, provided through UpToDate and accessed via the university's subscription service, was mistakenly described as a free resource. Therefore, the sentence \"pDDIs, defined using the lexi-interact (a free online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major)\" has been corrected as follows: - pDDIs, defined using the lexi-interact (an online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26798.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4404"},"PeriodicalIF":3.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit.\",\"authors\":\"M S Dagdelen, D Gulen, I Ceylan, N K Girgin\",\"doi\":\"10.26355/eurrev_202410_36861\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Correction to: Eur Rev Med Pharmacol Sci 2021; 25 (18): 5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 published online on September 30, 2021. The methodology section of this research article incorrectly stated that the lexi-interact checker program is freely accessible. The study was conducted at Uludağ University using university-access computers. As a result, the lexi-interact program, provided through UpToDate and accessed via the university's subscription service, was mistakenly described as a free resource. Therefore, the sentence \\\"pDDIs, defined using the lexi-interact (a free online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major)\\\" has been corrected as follows: - pDDIs, defined using the lexi-interact (an online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26798.\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"28 20\",\"pages\":\"4404\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202410_36861\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202410_36861","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

Correction to：Eur Rev Med Pharmacol Sci 2021; 25 (18)：5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 于 2021 年 9 月 30 日在线发表。本研究文章的方法论部分错误地指出，lexi-interact 检查程序可以免费获取。本研究是在乌鲁达大学使用学校提供的计算机进行的。因此，通过 UpToDate 提供并通过大学订阅服务访问的 lexii-interact 程序被错误地描述为免费资源。因此，"使用lexi-interact（UpToDate提供的免费在线交互作用检查程序，2020年，https://www.uptodate.com/drug-interactions）定义的pDDIs，根据交互作用的重要程度（轻微、中等、严重）进行分类 "这句话更正如下：- 使用lexi-interact（在线交互作用检查器，由UpToDate, 2020, https://www.uptodate.com/drug-interactions提供）定义的pDDIs根据交互作用的显著程度（轻微、中等、严重）进行分类。本文有一些修改。https://www.europeanreview.org/article/26798。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit.

Correction to: Eur Rev Med Pharmacol Sci 2021; 25 (18): 5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 published online on September 30, 2021. The methodology section of this research article incorrectly stated that the lexi-interact checker program is freely accessible. The study was conducted at Uludağ University using university-access computers. As a result, the lexi-interact program, provided through UpToDate and accessed via the university's subscription service, was mistakenly described as a free resource. Therefore, the sentence "pDDIs, defined using the lexi-interact (a free online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major)" has been corrected as follows: - pDDIs, defined using the lexi-interact (an online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26798.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European review for medical and pharmacological sciences 医学-药学

CiteScore

5.30

自引率

6.10%

发文量

906

审稿时长

2-4 weeks

期刊介绍： European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)